IP62-21: Delineating the Evolutionary Trajectory of Therapy Resistance in Prostate Cancer via Single-Cell Reconstruction to Develop and Validate a Clinically Actionable Cell-State Transition Signature

IP62-21: Delineating the Evolutionary Trajectory of Therapy Resistance in Prostate Cancer via Single-Cell Reconstruction to Develop and Validate a Clinically Actionable Cell-State Transition Signature

Sunday, May 17, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!